Year archive

Heidelberg Pharma AG — 2006 filings

All 4 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2006, sourced directly from the official regulator.

4 Filings

2006 Period

2006 filings (4)

Filing	Released	Lang
WILEX receives approval for clinical Phase II trial with oral WX-671 in pancreatic cancer Regulatory Filings	2006-12-15	English
WILEX enters into manufacturing and distribution agreement with IBA Molecular for the upcoming pivotal registration trial with CA9-SCAN Legal Proceedings Report	2006-12-13	English
WILEX shares successfully placed at EUR 13.80 Share Issue/Capital Change	2006-11-10	English
Price range for WILEX shares set at EUR 13.80 to EUR 15.80 Share Issue/Capital Change	2006-11-06	English

Filings by year